TROG Cancer Research
Members Login   CQMS Login

TD 17.11 (cPOST)


Title: Phase III trial of postoperative radiotherapy with or without REGN2810 in high risk cutaneous squamous cell carcinoma of the head and neck (cSCCHN). 

Primary Sponsor: Trans Tasman Radiation Oncology Group (TROG)

Collaborating Group:TBC

Trial development status: This investigator initiated study was approved for development on December 2018 by the TROG Scientific Committee.

QA program
Trial funding
Case report forms and database
HREC approval

Approximate date of trial activation: 2019

Trial chairs: 
Prof Danny Rischin, Peter MacCallum Cancer Centre
Prof Sandro Porceddu, Princess Alexandra Hospital

Trial contact:
Maria Farrell  
BaCT, Peter MacCallum Cancer Centre

Clinical trial registration: Coming soon

Trial Documents:

2018 ASM18 Presentation
EoI Template - NB: this is provided as a tool to aid completing the electronic survey
EOI Survey (Password: TROG)

Become a TROG member and join our community of over 1,000 health professionals.

Latest News

  • 12 Feb 2019

    a new clinical trial by trog cancer research has shown for the first time that a new radiotherapy technique produced greater survival rates in early stage inoperable lung cancer patients, compared to conventional radiation treatment. the trog 09.02 chisel study aimed to investigate if...

  • 29 Jan 2019

    results from australia’s and new zealand’s biggest cancer trial have identified the best treatment regime for men suffering from newly-diagnosed aggressive but localised prostate cancer. the radar study, run through trog cancer research, compared the use of hormone treatment (longer v...

  • 07 Aug 2018

    trog cancer research has been successful in being awarded a $1.5 million grant (2018-2020) under the cancer australia support for cancer clinical trials program. the funding from cancer australia provides essential infrastructure for trog to build our capacity to undertake cancer...

  • 07 Aug 2018

    the board of trog cancer research is pleased to announce the appointment of susan goode as the new trog chief executive officer. susan is formerly the centre manager for the hunter cancer research alliance at the university of newcastle. in this role, she was key player in a strate...